BRZE
Braze, Inc.
BRZE's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over BRZE overall, supported by stronger valuation and lower modeled downside.
BRZE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Healthy | |
| Unavailable |
BRZE's revenue and cash flow are currently healthy, but its profitability is under pressure. There isn't enough data to rate its balance sheet.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
BRZE PE Valuation
BRZE has no meaningful PE right now: it lost money over the past year.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
BRZE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
BRZE has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
BRZE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.89 | — |
| Q3 2026 | -$1.03 | +$0.01 |
| Q2 2026 | -$1.12 | -$0.11 |
| Q1 2026 | -$1.22 | -$0.20 |
| Q4 2025 | -$1.10 | +$0.03 |
| Q3 2025 | -$1.04 | +$0.13 |
| Q2 2025 | -$1.01 | +$0.26 |
| Q1 2025 | -$1.02 | +$0.30 |
| Q4 2024 | -$1.13 | +$0.26 |
BRZE is still losing money, but less than at its worst: $1.03 per share over the past year, against $1.47 at its worst in early 2023.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over BRZE on earnings quality, reporting a profit while its opponent remains loss making.
BRZE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $227.2M | +26% |
| Q2 2026 | $211M | +30% |
| Q1 2026 | $205.2M | +28% |
| Q4 2025 | $190.8M | +26% |
| Q3 2025 | $180.1M | +24% |
| Q2 2025 | $162.1M | +20% |
| Q1 2025 | $160.4M | +22% |
| Q4 2024 | $152.1M | +23% |
BRZE's revenue has grown year over year every quarter since early 2021: $227M last quarter, up 26% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -8% | +14 points |
| Q2 2026 | -13% | +12 points |
| Q1 2026 | -14% | -0.3 points |
| Q4 2025 | -20% | +1.8 points |
| Q3 2025 | -22% | -2.3 points |
| Q2 2025 | -25% | +4.8 points |
| Q1 2025 | -13% | +11 points |
| Q4 2024 | -21% | +6.9 points |
BRZE's operating margin was −8% last quarter, up 14 points from the same quarter a year ago, near the top of its range since 2020.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over BRZE on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over BRZE on profitability, with a higher operating margin.
BRZE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $23M | +431% |
| Q2 2026 | $28M | +17% |
| Q1 2026 | $14.6M | -9% |
| Q4 2025 | $19M | +$32.4M |
| Q3 2025 | $4.3M | -48% |
| Q2 2025 | $23.9M | +92% |
| Q1 2025 | $16M | +$18.5M |
| Q4 2024 | -$13.3M | -$8.3M |
BRZE generated $85M in free cash flow over the past year, up 174% from the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over BRZE on cash flow, with more consistent year-over-year improvement.
BRZE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +455K shares |
| 1 year | +4.2% | +4.4M shares |
| 3 years | +14% | +14.1M shares |
| 5 years | +23% | +21M shares |
| Available history | +554% | +94.2M shares |
BRZE has 111M diluted shares, up 4.2% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $50M |
| Q3 2021 | $3,000 |
| Q2 2021 | — |
| Q1 2021 | $212,000 |
| Q4 2020 | $1,000 |
| Q3 2020 | $500 |
| Q2 2020 | $500 |
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over BRZE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
BRZE Net Leverage
BRZE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
BRZE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 72.5 | Overbought |
| Stochastic | 98.9 | Overbought |
BRZE's weekly RSI is 73 (overbought) and its Stochastic is 99 (overbought).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
BRZE PE vs Technology Sector
BRZE has no meaningful PE right now: it lost money over the past year.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
BRZE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.5 | 28% above |
| 20 week MA | $30.8 | 51% above |
| 50 week MA | $26.5 | 76% above |
| 100 week MA | $29.6 | 57% above |
| 200 week MA | $35.5 | 31% above |
BRZE has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
BRZE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $94.2 | $77.2 | -18% |
| 2022 | $77.2 | $25.6 | -67% |
| 2023 | $25.6 | $53.1 | +108% |
| 2024 | $53.1 | $42.9 | -19% |
| 2025 | $42.9 | $35.4 | -17% |
| 2026 YTD | $35.4 | $46.6 | +32% |
BRZE has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.